Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy

People with HIV (PWH) on antiretroviral therapy (ART) still experience an increased risk of morbidity and mortality, presumably driven by chronic inflammation, yet predictors of discrete or combinatorial outcomes remain unclear. Galectin-9 (Gal-9), a driver of both inflammatory and immunosuppressive...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	AIDS (London) 2021-12, Vol.35 (15), p.2489-2495
Hauptverfasser:	Premeaux, Thomas A., Moser, Carlee B., McKhann, Ashley, Hoenigl, Martin, Laws, Elizabeth I., Aquino, Draven L., Lederman, Michael M., Landay, Alan L., Gianella, Sara, Ndhlovu, Lishomwa C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome Anti-HIV Agents - therapeutic use Bacterial Infections - etiology Biomarkers - blood Case-Control Studies Clinical Science: Concise Communication Galectins - blood HIV Infections - complications HIV Infections - drug therapy Humans Myocardial Infarction - etiology Neoplasms - etiology Stroke - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!